Biosimilars

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/physicochemical-and-biological-comparison-of-the-first-brazilian-biosi-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/adalimumab-a-review-of-the-reference-product-and-biosimilars-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/quotstepquot-versus-quotphasequot-in-the-clinical-development-of-biosi-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/tools-for-the-analysis-and-characterization-of-therapeutic-protein-spe-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/considerations-in-biosimilar-insulin-device-development-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/development-safety-and-efficacy-of-biosimilar-adalimumab-the-data-so-f-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/pharmacokinetic-and-pharmacodynamic-properties-of-a-new-biosimilar-fil-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/label-free-interaction-analysis-as-a-tool-to-demonstrate-biosimilarity-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/low-immunogenicity-but-reduced-bioavailability-of-an-interferon-beta-1-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/clinical-efficacy-and-safety-of-biosimilar-epoetin-focus-on-epoetin-ze-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/clinical-trials-in-the-development-of-biosimilars-future-consideration-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/establishing-a-new-marketplace-for-biologic-therapy-with-biosimilar-ag-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/challenging-issues-in-assessing-analytical-similarity-in-biosimilar-st-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/global-regulatory-landscape-of-biosimilars-emerging-and-established-ma-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/physicochemical-and-functional-characterization-of-a-biosimilar-adalim-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/production-and-manufacturing-of-biosimilar-insulins-implications-for-p-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/multidisciplinary-approach-to-evaluating-immunogenicity-of-biosimilars-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/production-and-analysis-of-a-biosimilar-erythropoietin-in-egypt-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/clinical-efficacy-and-safety-of-zarzioreg-ep2006-a-biosimilar-recombin-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/clinical-efficacy-and-safety-of-tevagrastimreg-xm02-a-biosimilar-recom-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/clinical-efficacy-and-safety-of-xm01-a-biosimilar-recombinant-human-er-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/clinical-efficacy-and-safety-of-sb309-a-biosimilar-recombinant-human-e-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/current-and-future-biosimilars-potential-practical-applications-in-rhe-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/rituximab-and-biosimilars-ndash-equivalence-and-reciprocity-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/similar-biotherapeutic-products-in-latin-america-regulation-and-opport-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/a-european-perspective-on-the-market-accessibility-of-biosimilars-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/the-development-and-introduction-of-biosimilar-anticoagulants-ndash-fo-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/clinical-efficacy-and-safety-of-hx575-a-biosimilar-recombinant-human-e-peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/critical-appraisal-of-biosimilar-filgrastim-nivestimtrade-for-febrile--peer-reviewed-fulltext-article-BS

Biosimilars is an international, peer-reviewed, open access journal focusing on the manufacture, development and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

https://www.dovepress.com/scientific-factors-for-assessing-biosimilarity-and-drug-interchangeabi-peer-reviewed-fulltext-article-BS